Because somatic mutation of TERT promoter and FGFR3, which were identified in the normal urothelium, have been reported as frequent mutations in tumor tissues by The Cancer Genome Atlas (TCGA), these mutations were thought to be potential drivers in the tumor formation of LG or HG NMIBC. The gene discussed is FGFR3; the disease is neoplasm.